MUNMED

Faculty of Medicine - Memorial University of Newfoundland
Vol. 10 No. 4 Fall 1998

CONTENTS

Top teaching award
First dean honoured
McGill principal calls for new model of health care
World's best-known geneticist vists MUN
New chair for the Discipline of Obs/Gyn
Healthways
New assistant dean for undergraduate medical education
Retirement
Revitalizing CME
Obituary
Humanities are the  Hormones
Historical diploma presented
Student affairs officer wins President's Award
Student Research Forum
A 50-year perspective
Of Note
Alumni News
New faculty
Student Perspective
A frontwards view
A backwards view
Letters
munbottom.gif (1559 bytes)

 

 


Dr. Yagang Xie

Assistant professor

Discipline of Laboratory Medicine

Dr. Yagang Xie's appointment fills a badly needed position at the Health Care Corporation as director of the Molecular Genetics Laboratory. For the past two years, little work has been done at the Janeway-based laboratory while the search went on for a qualified director.

xie.gif (23997 bytes)Dr. Xie brings an impressive background in clinical and research training to this position. He obtained his MD in 1983 from Henan University of Medical Science in Zhengzhou, China, and following a residency in internal medicine he worked as a research associate in the Division of Medical Genetics at the Henan Institute of Family Planning.

In 1992 Dr. Xie earned a doctorate in medical science from the University of Zurich in Switzerland, followed by a post-doctoral fellowship at the Karolinska Institute in Stockholm, Sweden. He then came to Canada as a post-doctoral fellow at the Centre for Research in Neuroscience at McGill University. He finished two years CCMG (Canadian College of Medical Genetics) training at Queen's University.

Dr. Xie says his combined education and experience in clinical medicine and basic science enables him to follow new developments in genetics and assess whether they will be transferred to clinical practice. He says Newfoundland is a wonderful place to do medical genetics, and he likes the challenge of developing a laboratory almost from the beginning.

According to the specific demand in Newfoundland, Dr. Xie has drawn up a plan for the initial development of molecular testing for certain hereditary cancer and mendelian diseases, which include colon cancer, breast cancer, multiple endocrine neoplasia type I and type II, Fragile X, Huntington's disease, spinocerebellar ataxia and cystic fibrosis.


Comments or questions e-mail: sgray@morgan.ucs.mun.ca Last update: 13 Jan 1999

MUNMED Home